Skip to content

Clinical research of ultrasound-guided ozonated water injection with single-segment puncture technique combined with manipulation in the treatment of primary frozen shoulder

Clinical research of ultrasound-guided ozonated water injection with single-segment puncture technique combined with manipulation in the treatment of primary frozen shoulder

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059471
Enrollment
Unknown
Registered
2022-04-30
Start date
2022-05-15
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary frozen shoulder

Interventions

experimental group:patients in experimental group will receive ozonated water injection combined with manipulation
control group:patients in control group will receive glucocorticoids injection combined with manipulation

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 65 years old; 2. Clinical symptoms consistent with PFS (pain and limited joint movement), the course of disease is >= 3 months, and the onset is unilateral; 3. NRS >= 4 points, at least two groups of flexion, extension, abduction, and external rotation have limited activity range > 30 degrees (compared with the healthy side).

Exclusion criteria

Exclusion criteria: 1. Shoulder fractures, dislocations, rotator cuff tears, or calcific tendonitis; 2. Shoulder pain caused by tuberculosis, tumor, neuropathy and other diseases; 3. Previous history of shoulder joint trauma or surgery; 4. Combined with pregnancy, infection, mental disorder, severe cardiovascular and cerebrovascular diseases, etc.; 5. Received other treatment options (except oral drugs) within 4 weeks; 6. Glycosylated hemoglobin is higher than 9%; 7. Those who are allergic to the drugs used; 8. Those with abnormal coagulation function.

Design outcomes

Primary

MeasureTime frame
Pain scores;Active range of motion;

Secondary

MeasureTime frame
Quality of sleeping;Patient’s satisfaction;The incidence of adverse reactions;The use of analgesics;Basic blood glucose value;

Countries

China

Contacts

Public ContactWen Shen

Xuzhou Medical University

shenwen670201@163.com+86 18052268689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026